You are here

  • Home
  • Archive
  • Volume 66, Issue 4
  • Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based first-line treatment failed

Article info

Article menu
Download PDFPDF
PostScript
Letter
Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based first-line treatment failed

Authors

  1. Correspondence to Dr Yasumi Katayama, Department of Gastroenterology, Dokkyo Medical University Koshigaya Hospital 2-1-50 Minami-Koshigaya, Koshigaya City, Saitama Prefecture 343-8555, Japan; yasumi{at}dokkyomed.ac.jp
View Full Text

Citation

Katayama Y, Toyoda K, Kusano Y, et al
Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based first-line treatment failed
Gut 2017;66:752-753.

Publication history

  • Received April 9, 2016
  • Revised April 21, 2016
  • Accepted April 25, 2016
  • First published May 17, 2016.
Online issue publication 
March 01, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/